In Silico Study of Pyrazoline Derivative Compounds against Eschericia coli Bacteria
DOI:
https://doi.org/10.30872/mpc.v13i.345Keywords:
Docking molecular, Eschericia coli, Pirazolina derivatives, PBP5Abstract
The development of antibiotics is needed to overcome drug resistance. Penicillin binding protein 5 (PBP5) Eschericia coli bacteria is one of the targets because it plays a role in maintaining cell shape. Pyrazolina is a compound that contains two nitrogen atoms where the two nitrogen atoms are close together and are responsible as an antibacterial agent that can disrupt the cell wall. The target molecule was downloaded from the Protein Data Bank (www.rcsb.org) (PDB ID: 6NTZ). The grid used is 20 ? x 26? x 32? with a center of 29,731?, -9,112 ? and 35,821 ?. Based on the results of the docking that has been carried out from 10 pyrazoline derivative test compounds, the resulting binding energy varies. There are 5 pyrazoline derivative compounds having binding energy lower than the natural ligands -6.27 kcal / mol. Compound P8 has the lowest value compared to other test compounds with a binding energy value of -7.69 kcal / mol. Based on the interaction, P2 and P3 compounds have interactions that are similar to the original ligands due to the presence of Pi-Donor hydrogen bonds with the amino acids SER 73 and SER 139. The results of molecular docking studies show that pyrazoline derivatives play a role in Eschericia coli bacteria.
References
[1] Nursamsiar, A. T. Toding, and A. Awaluddin, ?Studi In Silico Senyawa Turunan Analog Kalkon dan Pirimidin sebagai Antiinflamasi: Prediksi Absorpsi, Distribusi, dan Toksisitas,? Pharmacy, vol. 13, no. 01, pp. 92?100, 2016.
[2] Y. Bare, A. Maulidi, D. R. T. Sari, and S. S. N. D. Tiring, ?Studi in Silico Prediksi Potensi 6-Gingerol sebagai inhibitor c-Jun N-terminal kinases (JNK),? J. Jejaring Mat. dan Sains, vol. 1, no. 2, pp. 59?63, 2019, doi: 10.36873/jjms.v1i2.211.
[3] A. D. Bhoyar, Va. G. N., and R. P. R., ?Selection of parent trees for Rubber (Hevea brasiliensis) breeding based on RAPD analysis,? Nusant. Biosci., vol. 3, no. 3, pp. 118?123, 1970, doi: 10.13057/nusbiosci/n030303.
[4] A. A. Siddiqui and M. A. Rahman, ?Synthesis And Anticonvulsant Activity Of Some Substituted 3,5-Diphenyl-2-Pyrazoline-1-Carboxamide Derivatives,? Chem. Sci. J., vol. 1, no. 1, pp. 1?10, 2010, doi: 10.4172/2150-3494.1000006.
[5] J. Sriatun Sadiah1, Yuharmen2, ?SINTESIS DAN Uji Aktivitas Antibakteri Senyawa Analog Pirazoli Turunan3?bromokalkon Inti Naftalen,? E-Journal Chem., vol. 6, pp. 183?188, 2009.
[6] K. P. Safna Hussan, M. Shahin Thayyil, V. K. Rajan, and K. Muraleedharan, ?DFT studies on global parameters, antioxidant mechanism and molecular docking of amlodipine besylate,? Comput. Biol. Chem., vol. 80, no. March, pp. 46?53, 2019, doi: 10.1016/j.compbiolchem.2019.03.006.
[7] E. Sauvage et al., ?Crystal Structures of Complexes of Bacterial dd-Peptidases with Peptidoglycan-Mimetic Ligands: The Substrate Specificity Puzzle,? J. Mol. Biol., vol. 381, no. 2, pp. 383?393, 2008, doi: 10.1016/j.jmb.2008.06.012.
[8] E. Lukitaningsih, A. Wisnusaputra, and B. S. A. Sudarmanto, ?Scrining In Silico Active Compound Of Pachyrrhizus Erosus As Antitirosinase On Aspergillus Oryzae (Computattional Study With Homology Modeling And Molecular Docking),? Maj. Obat Tradis. (Traditional Med. Journal), vol. 20, no. 1, pp. 7?15, 2009.
[9] S. . Jadhav, S. R.A, G. K.W, and S. . GAIKWAD, ?Synthesis and antimicrobial studies of some novel pyrazolines,? Der Pharma Chem., vol. 3, no. 1, pp. 167?171, 2011.
[10] P. T. Chovatia, J. D. Akabari, P. K. Kachhadia, P. D. Zalavadia, and H. S. Joshi, ?Synthesis and selective antitubercular and antimicrobial inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives,? J. Serbian Chem. Soc., vol. 71, no. 7, pp. 713?720, 2006, doi: 10.2298/JSC0607713C.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Tri Wulan Novi, Wisnu Cahyo Prabowo, Fajar Prasetya (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.